Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein.
Yang Q, Xue B, Liu F, Lu Y, Tang J, Yan M, Wu Q, Chen R, Zhou A, Liu L, Liu J, Qu C, Wu Q, Fu M, Zhong J, Dong J, Chen S, Wang F, Zhou Y, Zheng J, Peng W, Shang J, Chen X.
Yang Q, et al. Among authors: chen x.
Signal Transduct Target Ther. 2024 Jun 10;9(1):144. doi: 10.1038/s41392-024-01858-5.
Signal Transduct Target Ther. 2024.
PMID: 38853183